
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Journal
- Events
- Suppliers
Suppliers
- Home
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Events
- Suppliers
Suppliers
Brandy Webb, N.D., Scientific Affairs manager at Probi, explores how GLP-1 therapies are reshaping nutrition science, product innovation, and metabolic health strategies. Seeing the microbiome as a metabolic infrastructure for GLP-1 signaling, she reveals actionable science that brands should be prioritizing now. Webb also touches on companion solutions backed by clinical evidence and how companies might navigate regulatory scrutiny tightening around peptides and grey-market products.
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Aging Is Inevitable. Longevity Is Negotiable
Sabinsa
















